GENTECH archive


Re: SE

The point about patenting is that the invention isn't really what's being
It's the time, money, effort etc that the inventor has put into the work.
There has to be a certain amount of difference, or the new product can be
classed as a copy of another product.
However, SE is less to do with this than with the end effect on the

David Wengraf
MA Biotechnological Law and Ethics
Sheffield University, UK.

>Trevor Lien,
>Sorry I must be thicker than a brick but if I understand your description
>of SE it is difficult to understand the basis for many biotech patents (I'm
>talking about Canada, which is where I live also).  I perfectly well
>understand the economic need for patents but, as someone who has always
>thought the chemical corporations made a huge mistake by not embracing
>labeling of their life science products,  it is tough to bring together the
>principles of SE and patenting.  It seems on the one hand they say
>everything is the same and on the other that it is completely different.
>Can we have it both ways?